It is a new structure of diazanone derivatives, as a potential long-acting, anti-allergic compounds with H1 receptor antagonist characteristics, clinically used in seasonal allergic conjunctivitis, seasonal/non-seasonal allergic rhinitis, acute and chronic urticaria and other allergic diseases, and belongs to the first line of clinical treatment.